- Home
- IKT vs GGT Comparison
IKT vs GGT Comparison
Compare IKT & GGT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IKT
- GGT
- Stock Information
- Founded
- IKT 2008
- GGT 1994
- Country
- IKT United States
- GGT United States
- Employees
- IKT N/A
- GGT N/A
- Industry
- IKT Biotechnology: Pharmaceutical Preparations
- GGT Trusts Except Educational Religious and Charitable
- Sector
- IKT Health Care
- GGT Finance
- Exchange
- IKT Nasdaq
- GGT Nasdaq
- Market Cap
- IKT 168.0M
- GGT 128.7M
- IPO Year
- IKT 2020
- GGT N/A
- Fundamental
- Price
- IKT $2.10
- GGT $4.32
- Analyst Decision
- IKT Buy
- GGT
- Analyst Count
- IKT 2
- GGT 0
- Target Price
- IKT $8.00
- GGT N/A
- AVG Volume (30 Days)
- IKT 111.4K
- GGT 59.7K
- Earning Date
- IKT 05-14-2025
- GGT 01-01-0001
- Dividend Yield
- IKT N/A
- GGT 15.56%
- EPS Growth
- IKT N/A
- GGT N/A
- EPS
- IKT N/A
- GGT 0.83
- Revenue
- IKT N/A
- GGT N/A
- Revenue This Year
- IKT N/A
- GGT N/A
- Revenue Next Year
- IKT N/A
- GGT N/A
- P/E Ratio
- IKT N/A
- GGT $6.90
- Revenue Growth
- IKT N/A
- GGT N/A
- 52 Week Low
- IKT $1.12
- GGT $4.32
- 52 Week High
- IKT $4.20
- GGT $7.00
- Technical
- Relative Strength Index (RSI)
- IKT 50.06
- GGT 36.96
- Support Level
- IKT $1.78
- GGT $4.43
- Resistance Level
- IKT $2.37
- GGT $4.56
- Average True Range (ATR)
- IKT 0.16
- GGT 0.11
- MACD
- IKT -0.00
- GGT -0.01
- Stochastic Oscillator
- IKT 54.70
- GGT 0.00
About IKT Inhibikase Therapeutics Inc.
Inhibikase Therapeutics Inc is a a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson's disease (PD), Parkinson's-related disorders and other diseases of the Abelson Tyrosine Kinases. Its multi-therapeutic pipeline has a primary focus on neurodegeneration and its program utilizing Risvodetinib (also known as IkT-148009), a selective inhibitor of the non-receptor Abelson Tyrosine Kinases, targets the treatment of Parkinson's disease inside and outside the brain as well as other diseases that arise from Abelson Tyrosine Kinases.
About GGT Gabelli Multi-Media Trust Inc. (The)
Gabelli Multimedia Trust Inc is a non-diversified closed-end management investment company. Its investment objective is the long-term growth of capital with income as a secondary objective. The fund invests majority of its assets, under normal market conditions, in common stock and other securities, including convertible securities, preferred stock, options, and warrants of companies in the telecommunications, media, publishing, and entertainment industries.